Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurogene
Biotech
Neurogene details death in Rett syndrome gene therapy trial
The biotech recommends using lower AAV doses and monitoring patients for the serious inflammatory condition that caused the patient's death.
Darren Incorvaia
May 16, 2025 3:00pm
Patient put in critical condition by Neurogene gene therapy dies
Nov 22, 2024 3:57am
Neurogene stops Batten gene therapy after FDA denies request
Nov 19, 2024 6:30am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
BioMarin CEO replaces commercial chief—Chutes & Ladders
Jan 19, 2024 8:30am
Neurogene inks Neoleukin reverse merger to fund gene therapies
Jul 18, 2023 8:47am
